168 related articles for article (PubMed ID: 24680976)
1. Immune reconstitution after allogeneic hematopoietic stem cell transplantation is associated with selective control of JC virus reactivation.
Tan CS; Broge TA; Ngo L; Gheuens S; Viscidi R; Bord E; Rosenblatt J; Wong M; Avigan D; Koralnik IJ
Biol Blood Marrow Transplant; 2014 Jul; 20(7):992-9. PubMed ID: 24680976
[TBL] [Abstract][Full Text] [Related]
2. Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient.
Balduzzi A; Lucchini G; Hirsch HH; Basso S; Cioni M; Rovelli A; Zincone A; Grimaldi M; Corti P; Bonanomi S; Biondi A; Locatelli F; Biagi E; Comoli P
Bone Marrow Transplant; 2011 Jul; 46(7):987-92. PubMed ID: 20921942
[TBL] [Abstract][Full Text] [Related]
3. Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy.
Lima MA; Marzocchetti A; Autissier P; Tompkins T; Chen Y; Gordon J; Clifford DB; Gandhi RT; Venna N; Berger JR; Koralnik IJ
J Virol; 2007 Apr; 81(7):3361-8. PubMed ID: 17229701
[TBL] [Abstract][Full Text] [Related]
4. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
[TBL] [Abstract][Full Text] [Related]
5. Human polyomavirus JC latency and reactivation status in blood of HIV-1-positive immunocompromised patients with and without progressive multifocal leukoencephalopathy.
Andréoletti L; Dubois V; Lescieux A; Dewilde A; Bocket L; Fleury HJ; Wattré P
AIDS; 1999 Aug; 13(12):1469-75. PubMed ID: 10465069
[TBL] [Abstract][Full Text] [Related]
6. Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML).
Khalili A; Craigie M; Donadoni M; Sariyer IK
J Neuroimmune Pharmacol; 2019 Dec; 14(4):649-660. PubMed ID: 31452013
[TBL] [Abstract][Full Text] [Related]
7. Development of multifocal leukoencephalopathy in patients undergoing allogeneic stem cell transplantation-can preemptive detection of John Cunningham virus be useful?
Avivi I; Wittmann T; Henig I; Kra-Oz Z; Szwarcwort Cohen M; Zuckerman T; Horowitz NA; Benyamini N
Int J Infect Dis; 2014 Sep; 26():107-9. PubMed ID: 25038519
[TBL] [Abstract][Full Text] [Related]
8. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy.
Koralnik IJ; Boden D; Mai VX; Lord CI; Letvin NL
Neurology; 1999 Jan; 52(2):253-60. PubMed ID: 9932940
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant.
Jelcic I; Jelcic I; Kempf C; Largey F; Planas R; Schippling S; Budka H; Sospedra M; Martin R
Ann Neurol; 2016 Mar; 79(3):404-18. PubMed ID: 26874214
[TBL] [Abstract][Full Text] [Related]
10. JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.
Khanna N; Wolbers M; Mueller NJ; Garzoni C; Du Pasquier RA; Fux CA; Vernazza P; Bernasconi E; Viscidi R; Battegay M; Hirsch HH;
J Virol; 2009 May; 83(9):4404-11. PubMed ID: 19211737
[TBL] [Abstract][Full Text] [Related]
11. Progressive multifocal leukoencephalopathy in patients receiving rituximab and cyclophosphamide after haplo-identical T-cell replete transplantation and review of the literature.
Salem R; Massoud R; Kanj SS; Hamdan M; Salman R; Bazarbachi A; El-Cheikh J
Curr Res Transl Med; 2017 Nov; 65(4):127-132. PubMed ID: 29132903
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the risk of polyomavirus JC reactivation in patients with immune-mediated diseases during long-term treatment with infliximab.
Giannecchini S; Clausi V; Vultaggio A; Macera L; Maggi F; Martelli F; Azzi A; Maggi E; Matucci A
J Neurovirol; 2012 Feb; 18(1):55-61. PubMed ID: 22281875
[TBL] [Abstract][Full Text] [Related]
13. HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity.
Iannetta M; Bellizzi A; Lo Menzo S; Anzivino E; D'Abramo A; Oliva A; D'Agostino C; d'Ettorre G; Pietropaolo V; Vullo V; Ciardi MR
J Neurovirol; 2013 Jun; 19(3):274-9. PubMed ID: 23715894
[TBL] [Abstract][Full Text] [Related]
14. Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies.
Bellizzi A; Nardis C; Anzivino E; Rodìo D; Fioriti D; Mischitelli M; Chiarini F; Pietropaolo V
J Neurovirol; 2012 Feb; 18(1):1-11. PubMed ID: 22290500
[TBL] [Abstract][Full Text] [Related]
15. Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy.
Wollebo HS; Safak M; Del Valle L; Khalili K; White MK
J Neuroimmunol; 2011 Apr; 233(1-2):46-53. PubMed ID: 21185609
[TBL] [Abstract][Full Text] [Related]
16. Determinants of survival in progressive multifocal leukoencephalopathy.
Marzocchetti A; Tompkins T; Clifford DB; Gandhi RT; Kesari S; Berger JR; Simpson DM; Prosperi M; De Luca A; Koralnik IJ
Neurology; 2009 Nov; 73(19):1551-8. PubMed ID: 19901246
[TBL] [Abstract][Full Text] [Related]
17. Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy.
Perkins MR; Ryschkewitsch C; Liebner JC; Monaco MC; Himelfarb D; Ireland S; Roque A; Edward HL; Jensen PN; Remington G; Abraham T; Abraham J; Greenberg B; Kaufman C; LaGanke C; Monson NL; Xu X; Frohman E; Major EO; Douek DC
PLoS Pathog; 2012; 8(11):e1003014. PubMed ID: 23144619
[TBL] [Abstract][Full Text] [Related]
18. Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy.
Gasnault J; Kahraman M; de Goër de Herve MG; Durali D; Delfraissy JF; Taoufik Y
AIDS; 2003 Jul; 17(10):1443-9. PubMed ID: 12824781
[TBL] [Abstract][Full Text] [Related]
19. Immune surveillance and response to JC virus infection and PML.
Beltrami S; Gordon J
J Neurovirol; 2014 Apr; 20(2):137-49. PubMed ID: 24297501
[TBL] [Abstract][Full Text] [Related]
20. Asymptomatic reactivation of JC virus in patients treated with natalizumab.
Chen Y; Bord E; Tompkins T; Miller J; Tan CS; Kinkel RP; Stein MC; Viscidi RP; Ngo LH; Koralnik IJ
N Engl J Med; 2009 Sep; 361(11):1067-74. PubMed ID: 19741227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
